Showing results (121-130 of 604) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|March 11, 2026
Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in FranceSamir Hamamah, Jeremy Carette, Henri Leleu, et al.
Pharmacoeconomics - Open|May 30, 2023
Perceptions and Attitudes Regarding Medical Device Development in Canada Among Canadian Innovators: A Qualitative StudyIkennah L Browne, Andrew J Sutton, Wei Zhang
Pharmacoeconomics - Open|February 10, 2024
Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language ModelsTim Reason, Emma Benbow, Julia Langham, et al.
Pharmacoeconomics - Open|March 15, 2024
A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with TrastuzumabSudewi Mukaromah Khoirunnisa, Fithria Dyah Ayu Suryanegara, Lisa Aniek de Jong, et al.
Pharmacoeconomics - Open|March 7, 2024
Identification and prioritisation of items for a draft participant-reported questionnaire to measure use of social care, informal care, aids and adaptationsKirsty M Garfield, Gail A Thornton, Samantha Husbands, et al.
Pharmacoeconomics - Open|August 4, 2023
Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn's Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims DatabasesChitra Karki, Dominick Latremouille-Viau, Inmaculada Gilaberte, et al.
Pharmacoeconomics - Open|April 13, 2026
Exploring the Sensitivity of Utilities Predicted by the EQ-5D, SF-6D, HUI3, 15D, AQoL-4D, and AQoL-8D Multi-Attribute Utility Instruments to SF-36 DimensionsJosephine N A Tetteh, Michael Schlander
Pharmacoeconomics - Open|April 15, 2026
Updated Health Economics Simulation Model of the Lifetime Progression of Multiple Sclerosis in an Australian SettingAndrew J Palmer, Ting Zhao, Glen Henson, et al.
Pharmacoeconomics - Open|October 11, 2023
Trade-Offs between Vaccine Effectiveness and Vaccine Safety: Personal versus Policy DecisionsSemra Ozdemir, Sean Ng, Vinh Anh Huynh, et al.
Pharmacoeconomics - Open|October 11, 2023
Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, CanadaReka E Pataky, Stirling Bryan, Mohsen Sadatsafavi, et al.
Pageof 61